14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.75 $7.35 Friday, 3rd May 2024 FATE stock ended at $4.06. This is 0.98% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 11.11% from a day low at $4.05 to a day high of $4.50.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Aug 26, 2021 $72.40 $74.02 $70.10 $71.25 722 482
Aug 25, 2021 $71.56 $73.82 $70.53 $72.94 745 283
Aug 24, 2021 $72.31 $72.89 $69.70 $71.53 1 780 616
Aug 23, 2021 $67.67 $72.29 $67.56 $72.27 2 908 683
Aug 20, 2021 $72.61 $73.00 $66.76 $67.01 6 448 405
Aug 19, 2021 $89.26 $90.61 $85.05 $85.63 1 460 836
Aug 18, 2021 $84.77 $91.90 $83.21 $91.00 1 331 732
Aug 17, 2021 $86.09 $86.50 $81.98 $84.44 988 531
Aug 16, 2021 $86.50 $88.06 $81.64 $87.63 789 415
Aug 13, 2021 $90.36 $90.36 $86.46 $86.71 524 196
Aug 12, 2021 $91.87 $92.70 $88.00 $90.06 620 424
Aug 11, 2021 $91.72 $91.72 $88.58 $91.54 512 996
Aug 10, 2021 $97.07 $97.43 $89.74 $90.69 694 031
Aug 09, 2021 $94.18 $96.50 $93.09 $95.73 503 196
Aug 06, 2021 $93.94 $96.00 $92.09 $95.42 824 039
Aug 05, 2021 $85.69 $95.88 $85.29 $95.54 1 176 826
Aug 04, 2021 $82.36 $85.92 $81.52 $85.73 562 724
Aug 03, 2021 $86.11 $86.11 $80.25 $83.25 773 480
Aug 02, 2021 $83.54 $86.08 $82.81 $85.08 623 806
Jul 30, 2021 $85.42 $86.91 $82.34 $82.80 436 370
Jul 29, 2021 $85.57 $88.46 $84.28 $86.04 831 919
Jul 28, 2021 $80.32 $84.92 $80.16 $84.82 641 825
Jul 27, 2021 $81.77 $82.75 $77.09 $80.14 965 561
Jul 26, 2021 $86.01 $86.93 $81.40 $83.01 554 650
Jul 23, 2021 $85.67 $86.85 $83.25 $86.19 691 372
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT